Author

S. Nathan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Bakovic· 1 shared A. Hussin· 1 shared A. J· 1 shared A. Narayanan· 1 shared A. P. Shah· 1 shared D. E. Conway· 1 shared F. Alenghat· 1 shared J. D. Paul· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Bakovic

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Sustainable and Ecofriendly Nanoparticle Synthesis Using Microbial Strains Isolated From Heavy Metal Rich Industrial Effluent

S. Nathan, S. Mathunny, A. J

This paper reports the synthesis of cobalt and copper nanoparticles using microbial strains from heavy metal-rich industrial effluent, achieving narrow size distribution under eco-friendly conditions.

bioRxiv · Mar 16, 2024 · PreprintMicrobiology

A Novel Amino Acid Deletion and Substitution in amrB Gene Associated with Gentamicin Susceptibility in Burkholderia pseudomallei from Malaysian Borneo

A. Hussin, S. Nathan, M. A. Shahidan, M. Y. Nor Rahim, M. Y. Zainun, N. A. N. Khairuddin, N. Ibrahim

The paper identifies novel mutations in the amrB gene of gentamicin-susceptible Burkholderia pseudomallei isolates from Malaysian Borneo and analyzes their impact on antibiotic resistance.

bioRxiv · May 31, 2023 · PreprintMicrobiology

Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture

K. Risner, K. V. Tieu, Y. Wang, M. Getz, A. Bakovic, N. Bhalla, S. Nathan, D. E. Conway, P. Macklin, A. Narayanan

This study identifies four FDA-approved drugs that inhibit SARS-CoV-2 infection in cell culture, with Maraviroc showing reduced S-protein mediated cell fusion.

bioRxiv · Aug 12, 2020 · PreprintMicrobiology

Monocyte and Macrophage Subtypes as Paired Cell Biomarkers for Coronary Artery Disease

K. A. Arnold, J. E. Blair, J. D. Paul, A. P. Shah, S. Nathan, F. Alenghat

The paper correlates CD16+ monocytes and M2 macrophages with coronary artery disease severity in patients.

bioRxiv · May 16, 2018Physiology